Liver transplantation in Baboons using 1,3-Galactosyltransferase gene-knockout pigs as donors

• Antragsteller: Privatdozent Dr. Matthias Heuer, Ph.D.
• Fachliche Zuordnung: Allgemein- und Viszeralchirurgie
• Förderung: Förderung von 2007 bis 2008
• Projektkennung: Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 38826163

As organ shortage is increasing, xenotransplantation may become a potential alternative to increase the number of organs to be transplanted. The swine appears to be the most suitable xenograft donor, because of the similarity of many of its organ systems and physiologic parameters to those of humans. But when a swine organ is transplanted into a primate, hyperacute rejection, induced by a single epitope, galactosyl-alpha-1,3-galactose (Gal), develops rapidly. To avoid this problem, recently genetically-engineered swine, alpha- 1,3-galactosyltransferase knockout (GalT-KO) miniature swine, that do not express the Gal epitope for human natural antibodies were generated. Initial studies undertaken with GalTKO swine kidney, kidney/thymus and heart transplantation have shown promising long-term results. The purpose of this study is to develop a primate model for long-term metabolic and immunosuppressive monitoring of liver xenotransplants obtained from GalT-KO swine. Baboons will undergo pig-to-baboon xenotransplantation. Achieving long-term survival using either standard immunosuppression or a tolerance-inducing protocol, we will monitor physiologic, metabolic and immunologic parameters in the transplant recipient to characterize the function of the xenograft.

• DFG-Verfahren: Forschungsstipendien
• Internationaler Bezug: USA
• Gastgeber: Dr. Martin Hertl; Professor Dr. David H. Sachs